Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 08:00 ET | Source: Cue Biopharma, Inc.

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T...
April 08, 2026 08:00 ET | Source: Artiva Biotherapeutics, Inc.

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Artiva Biotherapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference
April 08, 2026 07:50 ET | Source: 3E Network Technology Group Limited

Nasdaq Determines That 3 E Network Has Regained Compliance with Continued Listing Requirements

Nasdaq Determines That 3 E Network Has Regained Compliance with Continued Listing Requirements
April 08, 2026 07:47 ET | Source: Curanex Pharmaceuticals Inc

Curanex Highlights Five Additional Patient Cases Further Supporting the Potential of Its Lead Candidate in Cancer Cachexia, Advanced Cancer Supportive Care and Severe Systemic Decline

Expanded case series includes advanced thymic carcinoma, small cell lung cancer, pancreatic cancer, end-stage liver cirrhosis, and end-stage renal disease According to patient accounts, multiple...
April 08, 2026 07:30 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to REYOBIQ™ in Pediatric Malignant Gliomas

HOUSTON, April 08, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced...
April 08, 2026 07:30 ET | Source: Rocket Lab Corporation

Rocket Lab Completes at the Market Offering

Rocket Lab has completed its previously disclosed “at-the-market” equity offering program.
April 08, 2026 07:30 ET | Source: PMGC Holdings Inc.

PMGC Holdings Inc. [NASDAQ: ELAB] Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Multi-Sector Acquisition Strategy

PMGC Holdings Inc. [NASDAQ: ELAB] PMGC Holdings Fully Utilizes All Available in $20M Equity Financing Facility, Strengthens Cash Position and Advances Mult
April 08, 2026 07:00 ET | Source: Axsome Therapeutics, Inc.

Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today...
April 08, 2026 07:00 ET | Source: Tilray Brands, Inc.

Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

TORONTO, April 08, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. company (Nasdaq: TLRY; TSX: TLRY) a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis...
April 08, 2026 07:00 ET | Source: TScan Therapeutics, Inc.

TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference

WALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T...